Evidence map›Paper›PMID 37180221›Full record

ArticleJournal of cardiology cases2023

Development of pulmonary arterial hypertension following long-term Qing-Dai use for ulcerative colitis.

Yuta Inoue, Atsushi Ishihara, Teruki Mori, Syuntaro Horio, Takashi Yoshizane, Masazumi Arai, Toshiyuki Noda

Open access · hybridAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cardiology cases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Pharmaceutical biology · 2024
    Review
  2. Journal of pharmacopuncture · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yuta InoueGifu Prefectural General Medical Center, Department of Cardiovascular Surgery, Gifu city, Gifu, Japan.
Atsushi IshiharaGifu Prefectural General Medical Center, Department of Respiratory Support Center, Gifu city, Gifu, Japan.
Teruki MoriGifu Prefectural General Medical Center, Department of Respiratory Support Center, Gifu city, Gifu, Japan.
Syuntaro HorioGifu Prefectural General Medical Center, Department of Respiratory Support Center, Gifu city, Gifu, Japan.
Takashi YoshizaneGifu Prefectural General Medical Center, Department of Respiratory Support Center, Gifu city, Gifu, Japan.
Masazumi AraiGifu Prefectural General Medical Center, Department of Cardiovascular Internal Medicine, Gifu city, Gifu, Japan.
Toshiyuki NodaGifu Prefectural General Medical Center, Department of Cardiovascular Internal Medicine, Gifu city, Gifu, Japan.
Gifu Prefectural General Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 20-year-old woman using Qing-Dai for about 7 years for intractable ulcerative colitis was admitted to the emergency room because of dyspnea and syncope following exertion. The patient was diagnosed with drug-induced pulmonary arterial hypertension (PAH). Discontinuation of Qing-Dai rapidly improved PAH symptoms. The REVEAL 2.0 risk score, which is useful for assessing the severity of PAH and predicting prognosis, improved from high risk (12) to low risk (4) within 10 days. Discontinuing long-term use of Qing-Dai can rapidly improve Qing-Dai-induced PAH. Learning objective: Discontinuing the long-term use of Qing-Dai used for treating ulcerative colitis (UC) can rapidly improve Qing-Dai induced pulmonary arterial hypertension (PAH). REVEAL 2.0 risk score in patients who developed PAH due to Qing-Dai was useful for screening PAH in patients taking Qing-Dai for treatment of UC.

Indexed as

Drug-induced pulmonary arterial hypertensionQing-DaiUlcerative colitis

Identifiers

PMID37180221
PMCPMC10173393
OpenAlexW4321523279

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.